Wow, two separate news video drops in one day. I think

New Post Public Reply Private Reply Replies (1) Message Board
nmbr1stckpckr Java_guy #6238
606
Wow, two separate news video drops in one day. I think it's fair to say that news of this Company's tech is spreading. The first to hear of NNLX outside of our little group here will understandably approach consideration of investing with a highly speculative mindset. Only a few will put us on their watch list and even fewer will actually attempt to buy shares. Those that do will be whittled down even further when their brokerage refuses to let them buy the stock. So I still expect to see choppy trading (where the BID/ASK spread is at 10% or more) for a while.

That being said, any whiff of interest by a large healthcare company will be enough to cause volume to spike (~40M) with commensurate rise in SP (>$3.00). The frustrating part is that we probably won't see it coming. We will likely have to endure days where volume will have relatively dried up again allowing naysayers and bashers to attack our conviction in our investment with SP manipulation. It will not be much of a struggle for our little group to endure, but many new investors will likely be shaken.

I think a lot of the increased volume is attributable to momentum traders who were attracted to the stock after their stock screeners detected the spike in volume and SP. They tend to move on quickly which may explain some if not most of the selling in the last couple days. Likely not the profit they were hoping for, but enough to move on for now. Hard to say if these news events will give them pause or not.

It'll be a few more days or weeks before we see the next significant move up in SP ($0.30?). I am my moniker, but my timing is horrendous.
1

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

RION Completes Patient Enrollment for Innovative Diabetic Ulcer Study

Updated Category News Views 180

RION Completes Patient Enrollment for Innovative Diabetic Ulcer Study RION, a pioneering clinical-stage company focused on regenerative medicine, has reached a significant milestone by completing patient enrollment in its Phase 2 clinical trial for the Purified Exosome Product™ (PEP™). This innovative study aims to tackle the pressing problem of diabetic foot ulcers...

Continue Reading
Empowering Mental Health: BrainsWay's CME Course Initiative

Updated Category News Views 114

BrainsWay Leads in TMS Education Through Free CME Courses BURLINGTON, Mass. and JERUSALEM, Israel — BrainsWay, a leader in noninvasive neurostimulation treatments, is excited to announce its sponsorship of two free Continuing Medical Education (CME) courses. These courses aim to enhance mental health professionals' understanding and application of Transcranial Magnetic...

Continue Reading
OCCIN Reaches New Heights as Stock Surges to $23.52

Updated Category News Views 55

OCCIN Stock Hits New Heights In a notable market development, shares of OFS Credit Company (NASDAQ: OCCI) Inc. (OCCIN) have soared to an impressive 52-week high, reaching $23.52. This significant achievement reflects the steady upward trend of the investment firm, which primarily focuses on collateralized loan obligations. Over the last year, OCCIN's stock has shown...

Continue Reading
Rapid Micro Biosystems Plans Financial Results Announcement

Updated Category News Views 88

Rapid Micro Biosystems to Report Fourth Quarter Financials Rapid Micro Biosystems, Inc. (NASDAQ: RPID), a pioneering force in life sciences technology, is gearing up to unveil its fourth quarter and full-year financial outcomes for 2024. This milestone is set to take place on February 28, 2025, before the stock market opens, reflecting the company's commitment to...

Continue Reading
Bekaert's Latest Developments in Share Buyback and Liquidity

Updated Category News Views 337

Update on Share Buyback Program The share buyback journey continues for Bekaert with exciting developments outlined in their latest announcement. Recently, a significant milestone was reached as the company initiated a new tranche of its share buyback program. The aim of this program is clear: to enhance shareholder value by reducing the total number of outstanding...

Continue Reading